Safae TERRISSE

INSERM

France

Research Interests

Explore related searches

Professors in France Professors in Microbiology Microbiology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (12)

Laetitia Aymeric

Associate professor

Université d'Angers

FRANCE

View details

Emmanuel Clave

Université de Paris Faculté de Santé

FRANCE

View details

Valerio Iebba

Assistant Professor

University of Trieste

ITALY

View details

Isabelle Cremer

Sorbonne Université

FRANCE

View details

Mathieu Chevalier

Assistant Professor

FRANCE

View details

Markus Maeurer

University of Mainz

GERMANY

View details

Stergios Christodoulidis

Assistant Professor

CentraleSupélec

FRANCE

View details

LAURA MEZQUITA

University of Barcelona

SPAIN

View details

laurence ZITVOGEL

Université Paris-Saclay

FRANCE

View details

Janine Ziemons

University of Maastricht

NETHERLANDS

View details

Lisa Derosa

Assistant Professor

Université Paris-Saclay

FRANCE

View details

JULIEN MAZIERES

PROFESSOR

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Safae TERRISSE

Research Interests

Explore related searches

Contact this professor

Articles (18)

Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Impact of microbiota on breast cancer hormone therapy.

Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals.

Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy.

Cancer induces a stress ileopathy depending on B-adrenergic receptors and promoting dysbiosis that contribute to carcinogenesis.

Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?

Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era.

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index.

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment.

Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?

Immunodynamics of explanted human tumors for immuno-oncology.

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors.

The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer.

Collaborators (12)

Laetitia Aymeric

Emmanuel Clave

Valerio Iebba

Isabelle Cremer

Mathieu Chevalier

Markus Maeurer

Stergios Christodoulidis

LAURA MEZQUITA

laurence ZITVOGEL

Janine Ziemons

Lisa Derosa

JULIEN MAZIERES

Make your next move.